# ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study

> **NCT06715592** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 18 (actual)

## Conditions studied

- Paget Disease of the Vulva
- Vulva Cancer

## Interventions

- **DRUG:** Bleomicina

## Key facts

- **NCT ID:** NCT06715592
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-23
- **Primary completion:** 2025-03-31
- **Final completion:** 2027-02-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715592, "ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06715592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*